Akums Drugs and Pharmaceuticals share price rose 6 per cent to ₹505.90 in the intraday trade on the National Stock Exchange (NSE)
The drugmaker said Bafna will step down on December 31, 2025, after citing Delhi's pollution levels in his resignation letter
According to NSE bulk deal data, Ruby QC Investment Holdings Pte sold its entire stake of 4.62 per cent at ₹428 per share, while ICICI Prudential MF bought the same amount of shares through bulk deal
Despite this, the CDMO segment remained Akums' key growth driver, contributing Rs 804 crore, or 79 per cent of its total revenue